GPGI Investors Have Opportunity to Lead Securities Fraud Lawsuit
Rosen Law Firm is notifying purchasers of GPGI, Inc. f/k/a CompoSecure, Inc. securities who may have suffered losses during a specific class period to seek lead plaintiff status.
NEW YORK, NY – July 25, 2026 – Investors who purchased Class A common stock of GPGI, Inc. f/k/a CompoSecure, Inc. (NYSE: GPGI, CMPO) between November 3, 2025, and May 6, 2026, have an opportunity to serve as lead plaintiff in a securities fraud lawsuit. The deadline to file a motion to be appointed lead plaintiff is September 14, 2026.
The lawsuit alleges that defendants made materially false and misleading statements and failed to disclose critical information. According to the complaint, these misrepresentations include overstated valuations of a business called Husky, unrealistic revenue and EBITDA targets that lacked a reasonable basis, and that the acquisition of Husky was primarily motivated by the generation of fees for insiders rather than long-term shareholder value.
The Rosen Law Firm, which is representing investors in this matter, states that eligible investors may be entitled to compensation without paying out-of-pocket fees through a contingency fee arrangement. The firm encourages investors to select experienced counsel to represent their interests in the class action.
Investors can obtain more information about the class action and how to potentially participate by contacting the Rosen Law Firm. It is noted that no class has yet been certified in the action, and investors who do not seek to be a lead plaintiff may still benefit from any future recovery.